4.3 Article

Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson?s disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review

Guillaume Carey et al.

Summary: Anxiety symptoms in Parkinson's disease are associated with structural and functional changes in the fear and limbic cortico-striato-thalamocortical circuits. The neuropathology of PD may affect these circuits in different ways, which explains the high prevalence of anxiety and associated symptoms in PD.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

Frederic Sampedro et al.

PARKINSONISM & RELATED DISORDERS (2020)

Article Clinical Neurology

Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease

Massimo Filippi et al.

MOVEMENT DISORDERS (2020)

Article Neurosciences

A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment

Ignacio Aracil-Bolanos et al.

HUMAN BRAIN MAPPING (2019)

Article Clinical Neurology

Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up

Carme Uribe et al.

PARKINSONISM & RELATED DISORDERS (2019)

Review Clinical Neurology

Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis

Dimitrios Saredakis et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Clinical Neurology

Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarker

Frederic Sampedro et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Clinical Neurology

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort

Tanya Simuni et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Clinical Neurology

Cortical microstructural changes along the Alzheimer's disease continuum

Victor Montal et al.

ALZHEIMERS & DEMENTIA (2018)

Article Clinical Neurology

Anxiety in Parkinson's disease is associated with reduced structural covariance of the striatum

Caroline S. Oosterwijk et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Neurosciences

Impaired long contact white matter fibers integrity is related to depression in Parkinson's disease

Jia-Yong Wu et al.

CNS NEUROSCIENCE & THERAPEUTICS (2018)

Review Neurosciences

Non-motor features of Parkinson disease

Anthony H. V. Schapira et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Review Clinical Neurology

Depression rating scales in Parkinson's disease: A critical review updating recent literature

Elizabeth Torbey et al.

JOURNAL OF AFFECTIVE DISORDERS (2015)

Review Clinical Neurology

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

Javier Pagonabarraga et al.

LANCET NEUROLOGY (2015)

Article Multidisciplinary Sciences

The structural neural substrate of subjective happiness

Wataru Sato et al.

SCIENTIFIC REPORTS (2015)

Review Clinical Neurology

Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration

Philip S. J. Weston et al.

ALZHEIMERS RESEARCH & THERAPY (2015)

Review Clinical Neurology

Norepinephrine Deficiency in Parkinson's Disease: The Case for Noradrenergic Enhancement

Alberto J. Espay et al.

MOVEMENT DISORDERS (2014)

Article Clinical Neurology

Cortical Thinning Associated With Mild Cognitive Impairment in Parkinson's Disease

Barbara Segura et al.

MOVEMENT DISORDERS (2014)

Review Neurosciences

Tricks of the mind: Visual hallucinations as disorders of attention

James M. Shine et al.

PROGRESS IN NEUROBIOLOGY (2014)

Article Clinical Neurology

Parkinson's Disease-Cognitive Rating Scale: Psychometrics for Mild Cognitive Impairment

Ramon Fernandez de Bobadilla et al.

MOVEMENT DISORDERS (2013)

Review Clinical Neurology

Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease

J Marinus et al.

CLINICAL NEUROPHARMACOLOGY (2002)